138 related articles for article (PubMed ID: 9255435)
1. The effect of RheothRx Injection on the hemorheological parameters in patients with acute myocardial infarction.
Toth K; Bogar L; Juricskay I; Keltai M; Yusuf S; Haywood LJ; Meiselman HJ
Clin Hemorheol Microcirc; 1997; 17(2):117-25. PubMed ID: 9255435
[TBL] [Abstract][Full Text] [Related]
2. Hemorheological background of acetylsalicylic acid resistance.
Feher G; Koltai K; Kesmarky G; Toth K
Clin Hemorheol Microcirc; 2008; 38(3):143-52. PubMed ID: 18239256
[TBL] [Abstract][Full Text] [Related]
3. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I
Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745
[TBL] [Abstract][Full Text] [Related]
4. Effects of RheothRx on mortality, morbidity, left ventricular function, and infarct size in patients with acute myocardial infarction. Collaborative Organization for RheothRx Evaluation (CORE).
Circulation; 1997 Jul; 96(1):192-201. PubMed ID: 9236434
[TBL] [Abstract][Full Text] [Related]
5. The non-ionic surfactant Poloxamer 188 (RheothRx) increases plasma and whole blood viscosity.
Lechmann T; Reinhart WH
Clin Hemorheol Microcirc; 1998 Apr; 18(1):31-6. PubMed ID: 9653583
[TBL] [Abstract][Full Text] [Related]
6. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
[TBL] [Abstract][Full Text] [Related]
7. Hemorheological abnormalities in stable angina and acute coronary syndromes.
Lee BK; Durairaj A; Mehra A; Wenby RB; Meiselman HJ; Alexy T
Clin Hemorheol Microcirc; 2008; 39(1-4):43-51. PubMed ID: 18503109
[TBL] [Abstract][Full Text] [Related]
8. Follow-up of hemorheological parameters and platelet aggregation in patients with acute coronary syndromes.
Marton Z; Horvath B; Alexy T; Kesmarky G; Gyevnar Z; Czopf L; Habon T; Kovacs L; Papp E; Mezey B; Roth E; Juricskay I; Toth K
Clin Hemorheol Microcirc; 2003; 29(2):81-94. PubMed ID: 14610303
[TBL] [Abstract][Full Text] [Related]
9. Haemorheological parameters in young patients with acute myocardial infarction.
Zorio E; Murado J; Arizo D; Rueda J; Corella D; Simó M; Vayá A
Clin Hemorheol Microcirc; 2008; 39(1-4):33-41. PubMed ID: 18503108
[TBL] [Abstract][Full Text] [Related]
10. Effects of antihypertensive therapy on hemorheological profiles in female hypertensive patients with initially low or high whole blood viscosity.
Muravyov AV; Meiselman HJ; Yakusevich VV; Zamishlayev AV
Clin Hemorheol Microcirc; 2002; 26(2):125-35. PubMed ID: 12082261
[TBL] [Abstract][Full Text] [Related]
11. Hemorheological parameters and aging.
Feher G; Koltai K; Kesmarky G; Szapary L; Juricskay I; Toth K
Clin Hemorheol Microcirc; 2006; 35(1-2):89-98. PubMed ID: 16899911
[TBL] [Abstract][Full Text] [Related]
12. [Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].
Szapáry L; Szóts M; Horváth B; Márton Z; Alexy T; Késmárky G; Juricskay I; Nagy F; Gaál V; Pálfi A; Koltai K; Tóth K
Orv Hetil; 2003 Jun; 144(22):1085-90. PubMed ID: 12847818
[TBL] [Abstract][Full Text] [Related]
13. The effect of blood glucose levels on hemorheological parameters, platelet activation and aggregation in oral glucose tolerance tests.
Koltai K; Feher G; Kesmarky G; Keszthelyi Z; Czopf L; Toth K
Clin Hemorheol Microcirc; 2006; 35(4):517-25. PubMed ID: 17148851
[TBL] [Abstract][Full Text] [Related]
14. Effects of doxazosin on hemorheological, hemodynamic and lipid parameters in patients with essential hypertension.
Toth K; Nemes J; Czopf L; Kapronczay P; Kesmarky G; Juricskay I
Clin Hemorheol Microcirc; 1999; 20(1):57-61. PubMed ID: 11185685
[TBL] [Abstract][Full Text] [Related]
15. The effects of KBT-3022, a new anti-platelet agent, on hemorheological properties in guinea pigs.
Yamamoto N; Yokota K; Yamashita A; Oda M
Thromb Haemost; 1995 Jan; 73(1):118-21. PubMed ID: 7740482
[TBL] [Abstract][Full Text] [Related]
16. [Hemorheologic factors in hypertensive and diabetic retinopathy].
Vékási J; Márton Z; Késmárky G; Cser A; Russai R; Kovács B
Orv Hetil; 2001 May; 142(20):1045-8. PubMed ID: 11407065
[TBL] [Abstract][Full Text] [Related]
17. Effect of Sclerovit on endothelial dysfunction, hemorheological parameters, platelet aggregation, plasma concentration of homocysteine and progression of atherosclerosis in patients with vascular diseases.
Horvath B; Szapary L; Debreceni L; Feher G; Kenyeres P; Fulop A; Battyani I; Toth K
Clin Hemorheol Microcirc; 2009; 42(1):19-28. PubMed ID: 19363237
[TBL] [Abstract][Full Text] [Related]
18. The effect of aspirin on hemorheological parameters of patients with diabetic retinopathy.
Vekasi J; Koltai K; Gaal V; Toth A; Juricskay I; Kesmarky G
Clin Hemorheol Microcirc; 2008; 39(1-4):385-9. PubMed ID: 18503149
[TBL] [Abstract][Full Text] [Related]
19. The effect of simvastatin therapy on hemorheological profile in coronary heart desease (CHD) patients.
Muravyov AV; Yakusevich VV; Surovaya L; Petrochenko A
Clin Hemorheol Microcirc; 2004; 31(4):251-6. PubMed ID: 15567894
[TBL] [Abstract][Full Text] [Related]
20. [Hemorrheologic parameters in myocardial infarct during the hospitalization phase].
Tóth K; Bogár L; Simor T; Juricskay I; Jávor T
Orv Hetil; 1990 Jan; 131(1):15-9. PubMed ID: 2105476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
